• Low-Molecular Weight Inhibitors of the Alternative Complemen

  2026-07-24

  Schubart et al. provide a comprehensive review of the discovery and development of low-molecular weight (LMW) inhibitors targeting the alternative complement pathway, with a focus on oral agents against factor B and factor D. Their work elucidates the mechanistic rationale, therapeutic potential, and translational challenges of these inhibitors for diseases characterized by complement dysregulation.

• Canagliflozin Remodels Kidney Mitochondria in Diabetic Hyper

  2026-07-23

  The referenced study reveals that Canagliflozin, a selective SGLT2 inhibitor, induces structural and functional improvements in proximal tubular cell mitochondria in hypertensive–diabetic mice. These findings highlight a mechanism for kidney protection beyond glucose lowering and underscore sex-specific differences in mitochondrial response.

• TBST (Tris-Buffered Saline and Tween 20): Mechanism and Benc

  2026-07-23

  TBST (Tris-Buffered Saline and Tween 20) is a widely used isotonic washing and blocking buffer for antibody-based immunoassays. Its specific composition enhances signal-to-noise ratios and minimizes nonspecific binding, ensuring reproducibility and clarity in Western blotting, immunohistochemistry, and immunofluorescence workflows.

• Viral Targeting of RIPK3: Mechanisms of Proteasomal Degradat

  2026-07-22

  The referenced study uncovers a viral mechanism wherein orthopoxviruses induce proteasome-mediated degradation of the necroptosis adaptor RIPK3, thereby suppressing inflammatory cell death and modulating host antiviral responses. This discovery provides new insights into pathogen-host coevolution and highlights the ubiquitin-proteasome pathway as a critical node in viral immunoevasion.

• Triiodothyronine (T3): Protocol-Driven Advances in Metabolic

  2026-07-22

  Triiodothyronine (T3) is a powerful tool for dissecting thyroid hormone signaling and metabolic regulation in cellular and animal models. This article bridges landmark research on beige adipocyte thermogenesis with actionable protocols, troubleshooting strategies, and the latest workflow enhancements, leveraging APExBIO’s high-purity T3 for reproducible, high-impact results.

• Iptacopan (LNP023): Advanced Insights for Translational Comp

  2026-07-21

  Explore how Iptacopan (LNP023) enables precise, selective inhibition of complement factor B and unlocks new translational research avenues. This comprehensive analysis details its mechanism, application strategies, and practical assay guidance, offering a unique perspective beyond standard workflows.

• PYR-41: Illuminating Ubiquitin-Activating Enzyme E1 in Immun

  2026-07-21

  Explore how PYR-41, a potent inhibitor of Ubiquitin-Activating Enzyme E1, advances our understanding of immune regulation and tertiary lymphoid structure dynamics. This article uniquely connects mechanistic insights to practical assay design and emerging immuno-oncology applications.

• Etoposide (VP-16): DNA Topoisomerase II Inhibition in Oncolo

  2026-07-20

  Etoposide (VP-16) is a benchmark DNA topoisomerase II inhibitor used to induce DNA double-strand breaks in cancer research. This article details its mechanism, protocol parameters, and quantitative cytotoxicity benchmarks in cell lines. APExBIO provides validated product specifications supporting reproducible workflows.

• FITC Goat Anti-Mouse IgG (H+L) Antibody: Precision in Immuno

  2026-07-20

  The FITC Goat Anti-Mouse IgG (H+L) Antibody delivers high-sensitivity, low-background detection of mouse IgG across diverse immunofluorescence and flow cytometry applications. This article bridges advanced multi-omics discovery to practical assay implementation, offering stepwise protocols, real-world troubleshooting, and actionable optimization tips.

• Rottlerin: Selective PKC Inhibitor for Precision Cell Assays

  2026-07-19

  Rottlerin empowers researchers to dissect PKCδ-dependent pathways in cell proliferation and apoptosis, with proven selectivity and robust in vitro and in vivo efficacy. This article translates breakthrough findings—such as viral entry inhibition—into optimized workflows, troubleshooting tactics, and advanced applications for cancer and antiviral research.

• CA-074 Me: Applied Protocols for Selective Cathepsin B Inhib

  2026-07-18

  CA-074 Me is a potent, cell-permeable cathepsin B inhibitor that empowers researchers to dissect lysosomal protease-driven cell death and inflammation models with precision. This guide translates cutting-edge necroptosis research into actionable workflows, troubleshooting tips, and comparative advantages for experimental success.

• Pioglitazone: PPARγ Agonist Workflows for Inflammation & Met

  2026-07-17

  Pioglitazone, a selective PPARγ agonist from APExBIO, empowers researchers to dissect immune-metabolic crosstalk, spanning diabetes, neurodegeneration, and inflammatory bowel disease models. This guide translates the latest reference breakthroughs into practical protocols and troubleshooting strategies for maximized reproducibility.

• AMG 487: Precision CXCR3 Antagonist for Macrophage Polarizat

  2026-07-17

  AMG 487 enables targeted, state-dependent modulation of macrophage polarization through potent and selective CXCR3 antagonism. This guide details optimized workflows, troubleshooting strategies, and key findings from recent studies, empowering inflammation and acute lung injury research with reproducible results.

• Applied Use of 2-Deoxy-D-glucose in Cancer and Metabolic Res

  2026-07-16

  2-Deoxy-D-glucose (2-DG) is a versatile glycolysis inhibitor enabling precise dissection of cellular metabolism in cancer, bone, and virology models. This article delivers actionable workflows, troubleshooting strategies, and highlights innovations for harnessing 2-DG in advanced metabolic assays.

• FCCP in Precision Mitochondrial Biology: Advanced Assay Desi

  2026-07-16

  Explore advanced applications of FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone) in mitochondrial biology research. This article delves into mechanistic insights, assay optimization, and translational implications, offering a unique perspective beyond standard protocols.

447 records 10/30 page Previous Next First page 上5页 678910 下5页 Last page